Kaiser Permanente Colorado has issued a Request for Letters of Intent to participate in Project A-L-L.
Project A-L-L is based on a medication regimen that has been implemented with Kaiser Permanente diabetes patients, and has been shown to significantly reduce risk of heart attack and stroke. A-L-L stands for Aspirin, Lisinopril, and Lipid-Lowering Medication. Kaiser Permanente Colorado has partnered with 3 safety nets thus far to implement this quality improvement initiative. Kaiser Permanente recognizes that safety net clinics are essential community partners in our shared goals of improving the health of individuals and communities through population-based health care. Kaiser Permanente Colorado has committed $500,000 in 2012-2013 to continue and expand Project A-L-L, and fund up to 3 new safety net partners.
One question and answer webinar/conference call for potential applicants will take place on Thursday, March 22 from 10 a.m. to 11 a.m (MST). This webinar/call is optional. To ensure equitable and consistent communication to all applicants, no other questions about the request for LOI will be answered beyond this webinar/call. Please see the Request for Letter of Intent for the link to the webinar and conference call information.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment